Comments
In its second respiratory deal in two days, drugmaker Lupin Ltd has launched an inhalation-drug delivery device InspiraChamber under a licensing agreement with New Jersey-based respiratory research and development company InspiRX Inc.
Developed by InspiRX, the InspiraChamber ® anti-static valved holding chamber is a device that has been designed to enhance delivery of aerosol therapies. And the agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber in the US.
Valved holding chambers make it easier for young children and the elderly to take their asthma medicines. Depending on the treatment type, asthma medicines could either be for quick-relief/rescue or long-term control and they are administered via pressurised metered-dose inhalers, the company explained.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.